162 related articles for article (PubMed ID: 26489464)
1. Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease.
Srivastava R; Zhang J; Go GW; Narayanan A; Nottoli TP; Mani A
Cell Rep; 2015 Oct; 13(4):746-759. PubMed ID: 26489464
[TBL] [Abstract][Full Text] [Related]
2. LRP6 enhances glucose metabolism by promoting TCF7L2-dependent insulin receptor expression and IGF receptor stabilization in humans.
Singh R; De Aguiar RB; Naik S; Mani S; Ostadsharif K; Wencker D; Sotoudeh M; Malekzadeh R; Sherwin RS; Mani A
Cell Metab; 2013 Feb; 17(2):197-209. PubMed ID: 23395167
[TBL] [Abstract][Full Text] [Related]
3. Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
Cheng SL; Ramachandran B; Behrmann A; Shao JS; Mead M; Smith C; Krchma K; Bello Arredondo Y; Kovacs A; Kapoor K; Brill LM; Perera R; Williams BO; Towler DA
Circ Res; 2015 Jul; 117(2):142-56. PubMed ID: 26034040
[TBL] [Abstract][Full Text] [Related]
4. TCF7L2 (Transcription Factor 7-Like 2) Regulation of GATA6 (GATA-Binding Protein 6)-Dependent and -Independent Vascular Smooth Muscle Cell Plasticity and Intimal Hyperplasia.
Srivastava R; Rolyan H; Xie Y; Li N; Bhat N; Hong L; Esteghamat F; Adeniran A; Geirsson A; Zhang J; Ge G; Nobrega M; Martin KA; Mani A
Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):250-262. PubMed ID: 30567484
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3a.
Wang S; Song K; Srivastava R; Dong C; Go GW; Li N; Iwakiri Y; Mani A
FASEB J; 2015 Aug; 29(8):3436-45. PubMed ID: 25917329
[TBL] [Abstract][Full Text] [Related]
6. TCF7L2 transcriptionally regulates Fgf15 to maintain bile acid and lipid homeostasis through gut-liver crosstalk.
Bhat N; Esteghamat F; Chaube BK; Gunawardhana K; Mani M; Thames C; Jain D; Ginsberg HN; Fernandes-Hernando C; Mani A
FASEB J; 2022 Mar; 36(3):e22185. PubMed ID: 35133032
[TBL] [Abstract][Full Text] [Related]
7. Wild-type LRP6 inhibits, whereas atherosclerosis-linked LRP6R611C increases PDGF-dependent vascular smooth muscle cell proliferation.
Keramati AR; Singh R; Lin A; Faramarzi S; Ye ZJ; Mane S; Tellides G; Lifton RP; Mani A
Proc Natl Acad Sci U S A; 2011 Feb; 108(5):1914-8. PubMed ID: 21245321
[TBL] [Abstract][Full Text] [Related]
8. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
9. The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue.
Go GW; Srivastava R; Hernandez-Ono A; Gang G; Smith SB; Booth CJ; Ginsberg HN; Mani A
Cell Metab; 2014 Feb; 19(2):209-20. PubMed ID: 24506864
[TBL] [Abstract][Full Text] [Related]
10. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
Go GW
Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
[TBL] [Abstract][Full Text] [Related]
11. The interplay of canonical and noncanonical Wnt signaling in metabolic syndrome.
Abou Ziki MD; Mani A
Nutr Res; 2019 Oct; 70():18-25. PubMed ID: 30049588
[TBL] [Abstract][Full Text] [Related]
12. Mutant LRP6 Impairs Endothelial Cell Functions Associated with Familial Normolipidemic Coronary Artery Disease.
Guo J; Li Y; Ren YH; Sun Z; Dong J; Yan H; Xu Y; Wang DW; Zheng GY; Du J; Tian XL
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455246
[TBL] [Abstract][Full Text] [Related]
13. Heterozygosity for an inactivating mutation in low-density lipoprotein-related receptor 6 (Lrp6) increases osteoarthritis severity in mice after ligament and meniscus injury.
Joiner DM; Less KD; Van Wieren EM; Hess D; Williams BO
Osteoarthritis Cartilage; 2013 Oct; 21(10):1576-85. PubMed ID: 23756208
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis LRP6 novel mutations in patients with coronary artery disease.
Xu Y; Gong W; Peng J; Wang H; Huang J; Ding H; Wang DW
PLoS One; 2014; 9(1):e84345. PubMed ID: 24427284
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein receptor-related protein 6-mediated signaling pathways and associated cardiovascular diseases: diagnostic and therapeutic opportunities.
Kang S
Hum Genet; 2020 Apr; 139(4):447-459. PubMed ID: 32076828
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Targeting of LRP6 in Cardiovascular Diseases: Challenging But Not Wnt-Possible!
Labbé P; Thorin E
Can J Cardiol; 2019 Nov; 35(11):1567-1575. PubMed ID: 31679626
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
18. LRP6 dimerization through its LDLR domain is required for robust canonical Wnt pathway activation.
Chen J; Yan H; Ren DN; Yin Y; Li Z; He Q; Wo D; Ho MS; Chen Y; Liu Z; Yang J; Liu S; Zhu W
Cell Signal; 2014 May; 26(5):1068-74. PubMed ID: 24412751
[TBL] [Abstract][Full Text] [Related]
19. WNT Signaling Cascade Proteins and LRP6 in the Formation of Various Types of Coronary Lesions in Patients With Coronary Artery Disease.
Belenkov YN; Iusupova AO; Slepova OA; Pakhtusov NN; Popova LV; Lishuta AS; Krivova AV; Khabarova NV; Abidaev MY; Privalova EV
Kardiologiia; 2024 May; 64(5):3-10. PubMed ID: 38841783
[TBL] [Abstract][Full Text] [Related]
20. PTK7 modulates Wnt signaling activity via LRP6.
Bin-Nun N; Lichtig H; Malyarova A; Levy M; Elias S; Frank D
Development; 2014 Jan; 141(2):410-21. PubMed ID: 24353057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
